Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06848244 · ClinicalTrials.gov registry record · NA

Preventing Type 2 Diabetes in Black Emergent Adult

A NA study of Obesity and Type 2 Diabetes Mellitus, sponsored by University of North Carolina, Chapel Hill.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT06848244: Recruiting NA study of Obesity and Type 2 Diabetes Mellitus, sponsored by University of North Carolina, Chapel Hill.

NCT06848244 is a NA study of Obesity and Type 2 Diabetes Mellitus that is actively recruiting participants, run by University of North Carolina, Chapel Hill. The registered enrollment target is 100 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06848244, a NA study of Obesity and Type 2 Diabetes Mellitus, is actively recruiting participants, sponsored by University of North Carolina, Chapel Hill.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

Black Americans are disproportionately affected by diabetes, with nearly double the rates of type 2 diabetes mellitus (T2DM), compared to non-Hispanic White adults. Though numerous factors affect these disparities, one modifiable risk factor may be that of binge eating (BE), which increases risk for binge-eating disorder (BED), which is associated with severe obesity, and often precedes a T2DM diagnosis, beginning in childhood or adolescence. Nearly 30% of Black women with obesity report binge eating episodes. Furthermore, given that binge and overeating may disparately increase the odds of obesity in Black adults (15-fold increase vs. 6-fold increase in White adults), reducing this behavior will be critical to prevent continued disparities in T2DM diagnosis. Given that Black women have the highest rates of obesity in the nation (57%), report disparate rates of weight gain between young adulthood and mid adulthood, and report disparate rates of emotional eating in adolescence, which is a risk factor for BE, one pathway to reducing disparities in T2DM risk in Black women may be to reduce binge eating and prevent weight gain in emerging adulthood (ages 18-25).

Primary Outcome

Participants will self-monitor and complete surveys on binge eating episodes.

Interventions

  • BEHAVIORAL Diabetes Prevention Program (DPP)
  • BEHAVIORAL Appetite Awareness Training (AAT)

Study Locations (1)

North Carolina

  • UNC-Chapel Hill - Chapel Hill

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2025-06-30
Est. Completion 2030-12
Phase NA

What NCT06848244 shows while recruiting

NCT06848244 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (88% lower).

The record links to 4 conditions, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Diabetes Prevention Program (DPP) is the first listed.

NCT06848244 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT06848244 about?

NCT06848244 is a clinical study titled "Preventing Type 2 Diabetes in Black Emergent Adult". Black Americans are disproportionately affected by diabetes, with nearly double the rates of type 2 diabetes mellitus (T2DM), compared to non-Hispanic White adults. Though numerous factors affect these disparities, one modifiable risk factor may be that of binge eating (BE), which increases risk for...

What is the current status of trial NCT06848244?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-06-30. Estimated completion is 2030-12.

What conditions does trial NCT06848244 study?

This clinical trial studies the following conditions: Obesity, Type 2 Diabetes Mellitus, Binge-Eating Disorder, Binge Eating.

What interventions are being tested in trial NCT06848244?

The interventions under investigation include: Diabetes Prevention Program (DPP) (BEHAVIORAL), Appetite Awareness Training (AAT) (BEHAVIORAL).

Who is sponsoring clinical trial NCT06848244?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06848244 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06848244's enrollment target sits among peer trials

100 478th of 1053 higher than 555 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06848244, the US trial registry maintained by the National Library of Medicine. NCT06848244 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.